Since we last reported on enforcement actions in March 2015, FDA posted a notice from the N.C. Board of Pharmacy regarding the recall of certain lots of compounded pharmaceutical products. The notice does not identify specific contaminations but attributes the recall to general concerns about a North Carolina-based pharmacy's ability to ensure the sterility and potency of compounded products distributed in all 50 states. Separately, FDA announced another company's voluntary recall of certain IV solutions used in hemodialysis after samples were found contaminated with particulate matter. There were no recent recalls of medical devices posted on FDA's website.

View a complete listing of FDA Recalls.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.